SCHEMBL28429528

SCHEMBL28429528

COc1cc2nccc(Oc3ccc([N+](=O)[O-])c(Cl)c3)c2cc1NC=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 15/20 0.50
PDGFRA P16234 12/20 0.50
PDGFRB P09619 4/20 0.47
RET P07949 3/20 0.47
KIT P10721 3/20 0.47
FGFR1 P11362 3/20 0.47
FLT1 P17948 3/20 0.47
FLT4 P35916 3/20 0.47
RIPK2 O43353 2/20 0.47
STK10 O94804 2/20 0.47
ABL1 P00519 2/20 0.47
BCR P11274 2/20 0.47
SLC6A3 Q01959 2/20 0.47
DDR1 Q08345 2/20 0.47
MAP4K2 Q12851 2/20 0.47
PTK6 Q13882 2/20 0.47
DDR2 Q16832 2/20 0.47
AURKB Q96GD4 2/20 0.47
RIPK3 Q9Y572 2/20 0.47
ERN1 O75460 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25307750 0.87 PDGFRA (0.62) KDRPDGFRAPDGFRBFGFR2EGFR
SCHEMBL31616944 0.87 PDGFRA (0.62) KDRPDGFRAPDGFRBFGFR2EGFR
SCHEMBL19957201 0.86 KDR (0.56) KDRPDGFRAPDGFRBRETKIT
SCHEMBL28265725 0.84 KDR (0.52) KDRPDGFRAPDGFRBRETKIT
SCHEMBL19957375 0.84 KDR (0.53) KDRPDGFRAPDGFRBRETKIT
SCHEMBL28630533 0.83 KDR (0.53) KDRPDGFRAPDGFRBRETKIT
SCHEMBL19957062 0.83 MET (0.49) KDRPDGFRAPDGFRBRETKIT
SCHEMBL19957087 0.83 KDR (0.52) KDRPDGFRAPDGFRBRETKIT
SCHEMBL28646262 0.83 KDR (0.53) KDRPDGFRAPDGFRBRETKIT
SCHEMBL19957006 0.82 KDR (0.61) KDRPDGFRAPDGFRBRETKIT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111377865-A Preparation method of high-purity lenvatinib 北京启慧生物医药有限公司 2020-07-07 CN claimed
CN-111377865-A Preparation method of high-purity lenvatinib 北京启慧生物医药有限公司 2020-07-07 CN disclosed
CN-111377865-A Preparation method of high-purity lenvatinib 北京启慧生物医药有限公司 2020-07-07 CN disclosed